Coronation Fund Managers Ltd. Sells 12,278 Shares of Danaher Corporation $DHR

Coronation Fund Managers Ltd. decreased its holdings in shares of Danaher Corporation (NYSE:DHRFree Report) by 52.5% in the 1st quarter, HoldingsChannel reports. The firm owned 11,118 shares of the conglomerate’s stock after selling 12,278 shares during the period. Coronation Fund Managers Ltd.’s holdings in Danaher were worth $2,108,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of Danaher during the 4th quarter worth about $2,177,106,000. Viking Global Investors LP raised its holdings in Danaher by 543.9% in the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after acquiring an additional 2,455,994 shares during the period. Massachusetts Financial Services Co. MA lifted its position in Danaher by 104.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after acquiring an additional 2,216,789 shares during the last quarter. Wellington Management Group LLP lifted its position in Danaher by 11.2% during the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after acquiring an additional 1,517,904 shares during the last quarter. Finally, Capital International Investors boosted its holdings in shares of Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after acquiring an additional 1,487,768 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Trading Up 0.1%

DHR opened at $179.12 on Thursday. The stock has a market capitalization of $126.78 billion, a price-to-earnings ratio of 31.82, a P/E/G ratio of 2.19 and a beta of 0.79. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a 50-day simple moving average of $184.49 and a 200 day simple moving average of $197.34.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Tuesday, July 21st. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.06%. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period last year, the firm earned $0.77 EPS. Analysts predict that Danaher Corporation will post 8.49 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 30.95%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Citigroup began coverage on Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price on the stock. Barclays lowered their price objective on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. UBS Group reduced their target price on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Royal Bank Of Canada upped their price target on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday. Finally, Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average price target of $228.91.

View Our Latest Report on Danaher

Trending Headlines about Danaher

Here are the key news stories impacting Danaher this week:

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.